Context The diagnosis of familial partial lipodystrophy (FPLD) is currently made based on
clinical judgment. Objective There is a need for objective diagnostic tools that can diagnose …

Background Familial partial lipodystrophy (FPLD) is an inherited disorder of white adipose
tissue that causes premature cardiometabolic disease. There is no clear diagnostic criteria …

PURPOSE We aimed to investigate residual adipose tissue with whole-body magnetic
resonance imaging to differentiate between subtypes of lipodystrophy. METHODS A total of …

Context Partial lipodystrophy (PL) is associated with metabolic co‐morbidities but may go
undiagnosed as the disease spectrum is not fully described. Objective The objective of the …

Abstract Context Familial partial lipodystrophy, Dunnigan variety (FPLD2) is a rare
autosomal dominant disorder resulting from LMNA causal variants, which is characterized …

Objective To compare the risk of having polycystic ovary syndrome (PCOS) or ovarian cysts
among women with genetically confirmed familial partial lipodystrophy (FPLD) with that in …

Objective Type 1 and type 2 familial partial lipodystrophies (FPLD) are characterized by the
loss or increase in subcutaneous fat in certain body regions, as well as metabolic disorders …

Introduction: Familial partial lipodystrophy, Dunnigan variety (FPLD), an autosomal
dominant disorder caused by LMNA mutations, is characterized by fat loss from the …

OBJECTIVE. Familial partial lipodystrophy type 2 (Online Mendelian Inheritance in Man no.
151660) is a systemic disorder characterized by regional lipoatrophy and lipohypertrophy …

The objective of the study was to determine correlations between magnetic resonance
imaging (MRI) measures of truncal adiposity (trunk fat percentage [TrF% MRI], visceral …